Loxapine: a six-month evaluation in severely ill schizophrenic patients
Gallant, D.M.; Bishop, G.; Steel, C.A.; Bishop, M.P.
Current Therapeutic Research 15(4): 205-209
1973
ISSN/ISBN: 0011-393X PMID: 4633281 Document Number: 58010
Document emailed within 1 workday
Related Documents
Bishop, M.P.; Gallant, D.M. 1970: Loxapine: a controlled evaluation in chronic schizophrenic patients Current Therapeutic Research 12(9): 594-597Chouinard, G.; Annable, L.; DeMontigny, C.; Kropsky, M.L. 1977: Loxapine succinate in the treatment of newly admitted schizophrenic patients Current Therapeutic Research 21(1): 73-79
Bralet, M.C.; Yon, V.; Loas, G.; Noisette, C. 2000: Cause of mortality in schizophrenic patients: prospective study of years of a cohort of 150 chronic schizophrenic patients L'Encephale 26(6): 32-41
Hüfner, M. 1984: Problems in the evaluation of thyroid function parameters in severely ill patients Deutsche Medizinische Wochenschrift 109(51-52): 1981-1983
Simhandl, C.; Rogan, M.; Lesch, O.M.; Musalek, M.; Strobl, R. 1984: Value of professional and self evaluation scales in chronic schizophrenic patients Der Nervenarzt 55(7): 371-377
Gallant, D.M.; Bishop, M.P. 1970: Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients Current Therapeutic Research 12(6): 387-389
Sokolovich, G.E.; Tiutrin, I.I.; Shpisman, M.N. 1986: Evaluation of thrombosis risk in severely burned patients at the stage of acute burn toxemia Klinicheskaia Khirurgiia 3: 19-21
Klosińska, B.; Wierzbicki, T. 1973: Follow-up evaluation of remission and social adaptation in schizophrenic patients discharged against medical advice and in those discharged in the normal procedural way Psychiatria Polska 7(6): 601-606
Jochemsen, H. 1992: Life-prolonging and life-terminating treatment of severely handicapped newborn babies: a discussion of the Report of the Royal Dutch Society of Medicine on "Life-Terminating Actions with Incompetent Patients: Part I: Severely Handicapped Newborns" Issues in Law and Medicine 8(2): 167-181
Lancon, C.; Auquier, P.; Launois, R.; Toumi, M.; Llorca, P.M.; Bebbington, P.; Lehman, A. 2000: Evaluation of the quality of life of schizophrenic patients: validation of the brief version of the Quality of Life Interview L'Encephale 26(4): 11-16
1975: Loxapine (Loxitane) Medical Letter on Drugs and Therapeutics 17(25): 103
De la Gandara, J.; Dominguez, R.A. 1988: Lithium and loxapine: a potential interaction Journal of Clinical Psychiatry 49(3): 126
Nair, N.P.; Decker, B.L.; Schwartz, G. 1976: Loxapine succinate in the treatment of chronic schizophrenia Current Therapeutic Research 20(6): 802-809
Björvell, H.; Edman, G.; Rössner, S.; Schalling, D. 1985: Personality traits in a group of severely obese patients: a study of patients in two self-chosen weight reducing programs International Journal of Obesity 9(4): 257-266
Varga, E.; Simpson, G.M. 1971: Loxapine succinate in the treatment of uncontrollable destructive behavior Current Therapeutic Research 13(12): 737-742
Jeffries, J.; Bezchlibnyk-Butler, K.; Remington, G. 1992: Amenorrhea and galactorrhea associated with fluvoxamine in a loxapine-treated patient Journal of Clinical Psychopharmacology 12(4): 296-297
Nakano, S.; Onishi, K.; Onakado, H. 1988: On the discharge of schizophrenic patients--the status of families accepting the patients Nursing Technique 34(7): 838-848
Schaefer, R.M.; Teschner, M.; Heidland, A. 1989: Phospholipase a in severely ill patients Progress in Clinical and Biological Research 308: 757-762
Bogers, J.P.; de Jong, J.T. 1998: High incidence of admissions for schizophrenia in Surinam patients in the Netherlands not caused by preferential immigration of (pre)schizophrenic patients Nederlands Tijdschrift Voor Geneeskunde 142(9): 464-468
Azorin, J.M.; Bovier, P.; Widmer, J.; Tissot, R.; Jeanningros, R. 1992: Erythrocyte membrane transport of amino acid precursors of monoamines in schizophrenic patients. Comparison with depressive patients L'Encephale 18(5): 585-590